Susan Wang is a biotech associate on the health care team covering small-/mid-cap biotech stocks at T. Rowe Price Investment Management.

Susan's investment experience began in 2023, and she has been with T. Rowe Price since 2025, in her current role. Prior to this, Susan was employed by TCGX in San Franscisco as an investment associate covering both publics and private companies. Susan also consulted for Avego and NEA, conducting competitive analysis and portfolio management in early-stage biotech, and served as an investment intern at RTW.

Susan earned a Ph.D. in biomedical science, with an emphasis in epigenetics, from the University of California San Diego, School of Medicine. She also earned B.A. degrees in molecular and cell biology and psychology from the University of California, Berkeley.